INDEX VALUES   |

Home > Our Indexes > LSCIBP

Download Methodology

LifeSci Biotechnology Products Index


LifeSci Biotechnology Products Index ("LSCIBP") is an equal weighted index that is designed to measure the equity market performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering or product candidate that has received U.S. Food and Drug Administration approval. The inception date for LSCIBP was November 3, 2014.

LSCIBPS&P 500
Prior Day Closing Value7890.694771.02
Prior Day Change %+0.51%-0.59%
Current Value
Current Day Change %-0.70%+1.51%
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume
TickerCompanyLast Price$ Change% ChangeVolume

Index Characteristics (Oct 19, 2017)


No. of Constituents 36
Total Market Cap ($ in millions) 0
Mean Market Cap ($ in millions) 0
Median Market Cap ($ in millions) 0
Largest Constituent ($ in millions) 0
Smallest Constituent ($ in millions) 0

Market Cap Breakdown (Oct 19, 2017)


Top 10 Constituents (Oct 19, 2017)


Constituent Ticker Weight
Acorda Therapeutics Inc ACOR 3.90%
Sarepta Therapeutics Inc SRPT 3.86%
Enanta Pharmaceuticals Inc ENTA 3.72%
Exelixis Inc EXEL 3.52%
Biogen Inc BIIB 3.41%
Halozyme Therapeutics Inc HALO 3.39%
Neurocrine Biosciences Inc NBIX 3.38%
Retrophin Inc RTRX 3.36%
Acadia Pharmaceuticals Inc ACAD 3.30%
Nektar Therapeutics NKTR 3.24%
Data Updated Daily
Download All Constituents